Heinrich K, Stintzing S, Weikersthal LFV, Decker T, et al. Impact of sex on efficacy and safety of 1st-line treatment with FOLFIRI plus cetuximab or bevacizumab in RAS/BRAF wildtype metastatic colorectal cancer - A subgroup analysis of the FIRE-3 (AIO KRK-0306) trial. Eur J Cancer 2025;232:116133.
PMID: 41319450